Literature DB >> 12098256

Studies directed toward the total synthesis of discodermolide: asymmetric synthesis of the C1-C14 fragment.

Alexander Arefolov1, James S Panek.   

Abstract

[structure: see text] A convergent and stereoselective assembly of the C1-C14 subunit of marine natural product (+)-discodermolide has been completed. The approach employs chiral allylsilane bond construction methodology to establish four of the eight stereogenic centers. Key fragment coupling is achieved via an efficient stereoselective acetate aldol reaction between C1-C6 and C7-C14 subunits.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12098256     DOI: 10.1021/ol026139r

Source DB:  PubMed          Journal:  Org Lett        ISSN: 1523-7052            Impact factor:   6.005


  5 in total

1.  Efficient and selective syntheses of (all-E)- and (6E,10Z)-2'-O-methylmyxalamides D via Pd-catalyzed alkenylation--carbonyl olefination synergy.

Authors:  Guangwei Wang; Zhihong Huang; Ei-Ichi Negishi
Journal:  Org Lett       Date:  2008-07-02       Impact factor: 6.005

2.  Alkyne elementometalation-Pd-catalyzed cross-coupling. Toward synthesis of all conceivable types of acyclic alkenes in high yields, efficiently, selectively, economically, and safely: "green" way.

Authors:  Ei-Ichi Negishi; Guangwei Wang; Honghua Rao; Zhaoqing Xu
Journal:  J Org Chem       Date:  2010-05-21       Impact factor: 4.354

3.  Investigations into the use of a polyfluorooctanol as an auxiliary component for an aldol reaction.

Authors:  Jason Eames; Hasina Khanom
Journal:  Molecules       Date:  2004-04-30       Impact factor: 4.411

4.  Functional group compatibility. Propargyl alcohol reduction in the presence of a vinyl iodide.

Authors:  Richard W Denton; Kathlyn A Parker
Journal:  Org Lett       Date:  2009-07-02       Impact factor: 6.005

5.  A relay ring-closing metathesis synthesis of dihydrooxasilines, precursors of (Z)-iodo olefins.

Authors:  Qiuzhe Xie; Richard W Denton; Kathlyn A Parker
Journal:  Org Lett       Date:  2008-12-04       Impact factor: 6.005

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.